# ARDELYX, INC.: Form D filings

ARDELYX, INC., a pharmaceuticals company in Fremont, CA, filed 4 Form D notices with the SEC between 2010 and 2016. The latest, on August 1, 2016, reports $110 million sold of a $110 million offering to 31 investors.

Find out what ARDELYX, INC. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20ARDELYX%2C%20INC.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=ARDELYX%2C%20INC.&page=%2Fdata%2Fform-d%2Fcompany%2Fardelyx-inc-1437402)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20ARDELYX%2C%20INC.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=ARDELYX%2C%20INC.&page=%2Fdata%2Fform-d%2Fcompany%2Fardelyx-inc-1437402)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in California](https://specstream.ai/data/form-d/state/california): 5,891 rows, by operating companies, filed since November 1, 2024, $138.91, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/california
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 34175 ARDENWOOD BLVD., SUITE 200, Fremont, CA, 94555
- Phone: (510) 745-7047
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Delaware
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1437402

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Aug 1, 2016 | New notice | $110,000,008 | $110,000,008 | $0 | 31 | Jul 18, 2016 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1437402/000114036116074089/0001140361-16-074089-index.htm) |
| Jun 22, 2015 | New notice | $107,996,652 | $77,771,627 | $30,225,025 | 11 | Jun 5, 2015 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1437402/000114036115025017/0001140361-15-025017-index.htm) |
| Jul 7, 2011 | New notice | $22,283,445 | $17,578,665 | $4,704,780 | 11 | Jun 23, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1437402/000143740211000004/0001437402-11-000004-index.htm) |
| Dec 8, 2010 | New notice | $10,027,388 | $5,013,694 | $5,013,694 | 11 | Nov 16, 2010 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1437402/000143740210000004/0001437402-10-000004-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Annalisa Jenkins | Director |  |
| Paul Korner | Executive Officer |  |
| David Mott | Director |  |
| David Rosenbaum | Executive Officer |  |
| Elizabeth Grammer | Executive Officer |  |
| Michael Raab | Executive Officer, Director |  |
| Gordon Ringold | Director |  |
| Robert Bazemore | Director |  |
| Richard Rodgers | Director |  |
| Jeff Jacobs | Executive Officer |  |
| Mark Kaufmann | Executive Officer |  |
| William Bertrand, Jr. | Director |  |
| Jeremy Caldwell | Executive Officer |  |

## Other pharmaceuticals companies in California that filed recently

- [Anvion Bio, Inc.](https://specstream.ai/data/form-d/company/anvion-bio-inc-2158000) $100,000 · Oct 7, 2026
- [Aqur Biosciences, Inc.](https://specstream.ai/data/form-d/company/aqur-biosciences-inc-2094075) $1.5 million · Sep 18, 2026
- [BTB Therapeutics, Inc.](https://specstream.ai/data/form-d/company/btb-therapeutics-inc-2055053) $8.9 million · Aug 12, 2026

[Every Form D from the week of Aug 1, 2016](https://specstream.ai/data/form-d/week/2016-08-01) · [All recent filings in California](https://specstream.ai/data/form-d/state/california) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what ARDELYX, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).